Hepatitis C and liver transplantation

Gut

Volumn 45, Issue 2, 1999, Pages 159-163

  Berenguer, M ^a   Wright, T L ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; CYCLOSPORIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ARTICLE; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE;

EID: 0032838133     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.2.159     Document Type: Article

References (52)

1. Annual report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network Transplant Data: 1988-1994. Richmond, USA: United Network for Organ Sharing and the Division of Organ Transplantation, Bureau of Health Resources Development.
2. The European Liver Transplant Registry Report. Villejuif, France: Hōpital Paul Brousse, 1994.
3. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
4. Wright T, Donegun E, Hsu H, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-22.
5. Gretch D, Bacchi C, Corey L, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995;22:1-9.
6. Gane E, Portmann B, Naoumov N, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-20.
7. Prieto M, Berenguer M, Rayon M, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation relationship with rejection episodes. Hepatology 1999;29:250-6.
8. Ferrell L, Wright T, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992;16:865-76.
9. Wright TL, Combs C, Kim M, et al. Interferon alpha therapy for hepatitis C virus infection following liver transplantation. Hepatology 1994;20:773-9.
10. Feray C, Samuel D, Gigou M, et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995;22:1084-9.
11. Gane EJ, Tibbs CJ, Ramage JK, et al. Ribavirin therapy for hepatitis C infection following liver transplantation. Transpl Int 1995;8:61-4.
12. Cattral MS, Krajden M, Wanless IR, et al. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996;61:1483-8.
13. Gane EJ, Lo SK, Riordan SM, et al. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998;27:1403-7.
14. Bizollon T, Palazzo U, Ducerf C, et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997;26:500-4.
15. Ascher NL, Lake JR, Emond J, et al. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994;20:S24-7.
16. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-43.
17. Lock ASF, Chien D, Choo Q-L, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 1993;18:497-502.
18. Donegan E, Wright T, Roberts J, et al. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol 1995;104:673-9.
19. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-9.
20. Gane E, Naoumov N, Qian K, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996;110:1671-7.
21. Schluger L, Sheiner P, Thung S, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-6.
22. Boker KHW, Dalley G, Bahr MJ, et al. Long term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997;25:203-10.
23. Berenguer M, Ferrell L, Watson J, et al. Fibrosis progression in recurrent hepatitis C virus (HCV) disease: differences between the US and Europe [abstract]. Hepatology 1998;28:220A.
24. Rosen H, O'Reilly P, Shackleton C, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1997;62:1773-6.
25. Sheiner PA, Schluger LK, Emre S, et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surgery 1997;3:130-6.
26. Feray C, Gigou M, Samuel D, et al. Influence of genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-96.
27. Zhou S, Terrault N, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viraemia. Hepatology 1996;24:1041-6.
28. Gayowski T, Singh N, Marino I, et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha and outcome. Transplantation 1997;64:422-6.
29. Charlton M, Seaberg E, Wiesner R, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-30.
30. DiMartino V, Saurini F, Samuel D, et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997;26:1343-50.
31. Doughty AL, Spencer JD, Cossart YE, et al. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transplant Surgery 1998;4:15-21.
32. Sullivan DG, Wilson JJ, Carithers RL Jr, et al. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998;72:10036-43.
33. Pessoa MG, Bzowej NH, Kim M, et al. HCV quasispecies as a mechanism of severe post-transplantation (OLT) recurrence [abstract]? Hepatology 1998;28:165A.
34. Casavilla FA, Rakela J, Kapur S, et al. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transplant Surgery 1998;4:448-54.
35. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995;21:30-4.
36. Berenguer M, Prieto M, Córdoba J, et al. Early development of chrome active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998;28:756-63.
37. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997;92:1453-7.
38. Rosen HR, Gretch DR, Oehlke M, et al. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998;65:1178-82.
39. Manez R, Mateo R, Tabasco J, et al. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1994;59:640-2.
40. Rosen H, Chou S, Corless C, et al. Cytomegalovirus viraemia. Risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-6.
41. Huang E, Wright TL, Lake J, et al. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996;23:396-404.
42. Berenguer M, Terrault NA, Piatak M, et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996;111:1569-75.
43. Feray C, Gigou M, Samuel D, et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998;128:810-16.
44. International Interferon-α Hepatocellular Carcinoma Study Group. Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 1998;351:1535-9.
45. Kasahara A, Hayashi N, Mochizuki K, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998;27:1394-1402.
46. Serfarty L, Aumaitre H, Chazouillères, O, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-440.
47. Liang TJ. Combination therapy for hepatitis C infection. N Engl J Med 1998;339:1549-50.
48. Sheiner P, Boros P, Klion FM, et al. The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998;28:831-8.
49. Singh N, Gayowski T, Wannstedt C, et al. Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant recipients. Transplantation 1998;65:82-6.
50. Mazzaferro V, Regalia E, Pulvirenti A, et al. Prophylaxis against HCV recurrence after liver transplantation. Effect of interferon and ribavirin combination. Transplant Proc 1997;29:519-21.
51. Singh N, Gayowski T, Wannstedt CF, et al. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy. Clin Transplant 1996;10:348-51.
52. Shiffman M, Contos M, Luketic V, et al. Biochemical and histological evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994;57:526-32.